The latest in psychiatric therapies and management
Latest Therapies Articles
Results of brain imaging studies demonstrate that "hypnosis influences all of the cortical areas and neurophysiological processes that underlie pain and emotions."
The ADA released detailed guidelines for psychosocial assessments and care based on factors including age, type of diabetes, and family support system.
The major issues of drug development are that pre-clinical animal efficacy studies do not accurately predict human efficacy, and clinical trials often inaccurately fail to show drug efficacy.
Connectivity in the right midfrontal gyrus may help predict placebo response. This finding has widespread implications in drug development.
The crystal structure may provide inspiration for designing drugs that refine efficacy and avoid adverse events.
Laughing about 10 minutes every day has similar benefits to eating vegetables, exercising, and meditating.
Dialectical behavioral therapy uses the concept of "radical acceptance" to help manage the psychological and emotional aspects of chronic pain.
Regular evaluation and assessment along with a personalized "step approach" is essential for effective pain management.
While treatments for pain often target either the brain or the body, data show treatments often benefit both.
Combined pharmacologic and behavioral treatment approaches are more beneficial than either approach alone for chronic pain conditions.
Drug News from MPR
Psychiatry Advisor Articles
- Naltrexone-Assisted Detox vs Buprenorphine Taper for Opioid Dependence
- Suicide Prevention and Intervention: Cross-Cultural Perspectives
- Pediatric Patients Should Undergo Electrocardiogram Assessment Before Antipsychotic Treatment
- Which Antidepressants May Cause Birth Defects?
- Best Practices for Treatment of Bipolar Disorder